Skip to main content

Alagille Syndrome (ALGS): A study on the long-term safety and effectiveness of Livmarli

This study is being done for children: • With a Alagille Syndrome (AlGS) diagnosis • Currently taken Livmarli. The purpose of this research study is to evaluate the long-term safety and outcomes of patients with Alagille Syndrome (ALGS) who are prescribed Livmarli (maralixibat).

Interested in learning more?

Full Study Name: LEAP

Investigator

CATEGORIES